Tevogen Bio Holdings Inc. TVGN
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-11-04
Tevogen Bio Holdings Inc. statistics & valuation
Market cap$29.5M
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Return on assets | -599.5% | -396.6% | -1098.5% | 1.2% |
| Return on equity | 319.1% | 205.7% | 64.0% | -13.0% |
| Current ratio | 0.22 | 0.26 | 0.02 | 0.78 |
Source: SEC EDGAR filings · CIK 0001860871 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.